Drugs / FS VH S/D 500 s-apr
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00892957 | Jul 2009 → Oct 2010 | — | Baxter Healthcare Corporation | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FS VH S/D 500 s-apr | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00892957 ↗ |
| Modality | Protein / enzyme biologic | “Biological two-component fibrin sealant” NCT00892957 ↗ |